Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

Extension Study of IONIS-GHR-LRx Administered to Participants With Acromegaly Being Treated With Long-acting Somatostatin Receptor Ligands

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03967249
Recruitment Status : Completed
First Posted : May 30, 2019
Last Update Posted : August 8, 2022
Information provided by (Responsible Party):
Ionis Pharmaceuticals, Inc.

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : March 31, 2022
Actual Study Completion Date : July 7, 2022